Why GLP-1?

Trusted brands in one place
Clinically proven for weight loss
Doctor-guided programs
No in-person appointments needed
Trusted brands in one place
Trusted brands in one place

Explore GLP-1's
News & Updates

Learn more about GLP'-1's latest news & updates

Explore By Category

All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
How Big Tech Is Reshaping the GLP-1 Medication Landscape
News & Updates

How Big Tech Is Reshaping the GLP-1 Medication Landscape

The GLP-1 medication boom isn't just attracting pharmaceutical companies anymore. Major technology players are positioning themselves to capitalize on the weight loss drug wave—and for patients currently on or considering GLP-1 therapy, that shift could matter more than you think.

Read More
Ozempic Safety: What One Family's Loss Teaches Us
Side Effects & Safety

Ozempic Safety: What One Family's Loss Teaches Us

A widow has gone public with a warning following her husband's death, which she links to his use of Ozempic. While investigations are ongoing, her story is a sobering reminder that no medication is without risk — and that informed, supervised use is non-negotiable.

Read More
Gut Reset After Ozempic: Can It Stop Rebound Weight Gain?
GLP-1 Agonists

Gut Reset After Ozempic: Can It Stop Rebound Weight Gain?

One of the most common fears among people on GLP-1 medications is what happens when they stop. New research points to a promising gut-based strategy that may help hold off rebound weight gain — and it's simpler than you might expect.

Read More
Why People Judge GLP-1 Weight Loss Differently
Weight Loss

Why People Judge GLP-1 Weight Loss Differently

Research confirms what many GLP-1 users already feel — that losing weight with medication invites more criticism than losing it "the old-fashioned way." Understanding why this happens can help you protect your mental health and stay on track with your treatment.

Read More
Oral Semaglutide Shows Promise for Kids with Type 2 Diabetes
News & Updates

Oral Semaglutide Shows Promise for Kids with Type 2 Diabetes

Novo Nordisk just announced positive results from its PIONEER TEENS trial, testing oral semaglutide in children and adolescents with type 2 diabetes. If approved, it could be the first oral GLP-1 medication available for kids ages 10–17. Here's what the data means and why it matters.

Read More
Medicare's GLP-1 Pilot Is Dead: What It Means for You
News & Updates

Medicare's GLP-1 Pilot Is Dead: What It Means for You

The Trump administration has quietly pulled the plug on a Medicare pilot program that would have expanded access to GLP-1 weight loss medications for seniors. If you're on Medicare and counting on that coverage, here's what you need to know — and what your options actually are.

Read More
Wegovy & Mounjaro Flagged for Abuse Risk: What It Means
News & Updates

Wegovy & Mounjaro Flagged for Abuse Risk: What It Means

South Korea's Ministry of Food and Drug Safety has officially designated Wegovy and Mounjaro as drugs with abuse concerns. This doesn't mean these medications are dangerous or being banned — but it does signal something worth understanding if you're on GLP-1 therapy.

Read More
Why Insurers Are Skipping the Medicare GLP-1 Pilot
GLP-1 Agonists

Why Insurers Are Skipping the Medicare GLP-1 Pilot

A Medicare pilot program designed to bring GLP-1 medications to older adults at a steep discount is losing steam — because insurers won't participate. Understanding why they're walking away matters if you're a senior counting on coverage for semaglutide or tirzepatide.

Read More
Is "Ozempic Personality" Real? What the Research Says
GLP-1 Agonists

Is "Ozempic Personality" Real? What the Research Says

A growing number of people on GLP-1 medications are reporting more than just weight loss — they're noticing changes in their mood, motivation, and emotional range. Is "Ozempic personality" a real side effect, or something else entirely? Here's what the evidence actually shows.

Read More